Bill119th CongressFiled Jul 21, 2026
S. 5043
A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedJul 21, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Budd, Ted [R-NC](R-NC)Sponsor